Funds holding Ascendis Pharma A/S
ISIN US04351P1012 · Denmark · LEI 549300B66JN3W3J8GH73
- Fund holders
- 180
- Of which ETFs
- 21 159 other funds
- Value held
- 3.3B $ 118M SEK · 181.5K €
This issuer has other securities : Ascendis Pharma A/S (DK0060615755)
180 funds hold this company. This table lists the 179 that declare it in a regulatory filing. 1 more fund publishes its holdings in its own report. It is not in the table.
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| Alger Capital Appreciation Portfolio ALGER PORTFOLIOS | 9,149 | 2.1M $ | 0.32 % | as of Mar 31, 2026 ↗ |
| Destinations Small-Mid Cap Equity Fund Brinker Capital Destinations Trust | 9,029 | 2.1M $ | 0.28 % | as of Feb 28, 2026 ↗ |
| Invesco V.I. Small Cap Equity Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 8,705 | 2M $ | 1.27 % | as of Mar 31, 2026 ↗ |
| State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS | 8,289 | 1.9M $ | 0.40 % | as of Mar 31, 2026 ↗ |
| Allspring VT Discovery SMID Cap Growth Fund Allspring VARIABLE TRUST | 8,217 | 1.9M $ | 1.45 % | as of Mar 31, 2026 ↗ |
| Franklin Small-Mid Cap Growth VIP Fund Franklin Templeton Variable Insurance Products Trust | 8,215 | 1.9M $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Fidelity Advisor Series Growth Opportunities Fund Fidelity Advisor Series I | 8,116 | 1.9M $ | 0.19 % | as of Feb 28, 2026 ↗ |
| HUSSMAN STRATEGIC MARKET CYCLE FUND Hussman Investment Trust | 8,000 | 1.8M $ | 0.46 % | as of Mar 31, 2026 ↗ |
| LVIP T. Rowe Price Structured Mid-Cap Growth Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 7,192 | 1.6M $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Franklin DynaTech VIP Fund Franklin Templeton Variable Insurance Products Trust | 7,184 | 1.6M $ | 1.04 % | as of Mar 31, 2026 ↗ |
| Invesco V.I. Health Care Fund AIM Variable Insurance Funds (Invesco Variable Insurance Funds) | 7,074 | 1.6M $ | 1.09 % | as of Mar 31, 2026 ↗ |
| Brighthouse/Wellington Large Cap Research Portfolio Brighthouse Funds Trust I | 6,634 | 1.5M $ | 0.07 % | as of Mar 31, 2026 ↗ |
| Brown Advisory Sustainable Small-Cap Core Fund Brown Advisory Funds | 6,593 | 1.5M $ | 1.43 % | as of Mar 31, 2026 ↗ |
| Sit Small Cap Growth Fund SIT MUTUAL FUNDS INC | 6,300 | 1.4M $ | 1.15 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Capital Appreciation Premium Income ETF T. Rowe Price Exchange-Traded Funds, Inc. | 6,204 | 1.4M $ | 0.52 % | as of Mar 31, 2026 ↗ |
| Transamerica T. Rowe Price Small Cap VP TRANSAMERICA SERIES TRUST | 6,149 | 1.4M $ | 0.22 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Series Funds | 5,974 | 1.4M $ | 1.01 % | as of Mar 31, 2026 ↗ |
| AdvisorShares Dorsey Wright ADR ETF AdvisorShares Trust | 5,750 | 1.3M $ | 2.91 % | as of Mar 31, 2026 ↗ |
| Baron Health Care Fund BARON SELECT FUNDS | 5,600 | 1.3M $ | 1.07 % | as of Mar 31, 2026 ↗ |
| Diversified International Account Principal Variable Contract Funds, Inc | 5,349 | 1.2M $ | 0.48 % | as of Mar 31, 2026 ↗ |
| VY(R) T. ROWE PRICE DIVERSIFIED MID CAP GROWTH PORTFOLIO Voya Partners Inc | 5,346 | 1.2M $ | 0.14 % | as of Mar 31, 2026 ↗ |
| Penn Series Mid Cap Growth Fund Penn Series Funds Inc | 5,145 | 1.2M $ | 1.10 % | as of Mar 31, 2026 ↗ |
| Capital Appreciation Portfolio PACIFIC SELECT FUND | 4,554 | 1M $ | 1.02 % | as of Mar 31, 2026 ↗ |
| AlphaCentric Life Sciences and Healthcare Fund MUTUAL FUND SERIES TRUST | 4,526 | 1M $ | 2.63 % | as of Mar 31, 2026 ↗ |
| Penn Series Small Cap Growth Fund Penn Series Funds Inc | 4,229 | 967.3K $ | 1.10 % | as of Mar 31, 2026 ↗ |
| Driehaus Small/Mid Cap Growth Fund Driehaus Mutual Funds | 4,087 | 934.8K $ | 1.04 % | as of Mar 31, 2026 ↗ |
| Fidelity Disruptive Medicine ETF Fidelity Covington Trust | 3,865 | 902.5K $ | 1.48 % | as of Feb 28, 2026 ↗ |
| AVIP AB Small Cap Portfolio AuguStar Variable Insurance Products Fund Inc | 3,516 | 804.2K $ | 0.30 % | as of Mar 31, 2026 ↗ |
| Invesco Nasdaq Biotechnology ETF Invesco Exchange-Traded Fund Trust II | 3,474 | 811.2K $ | 1.07 % | as of Feb 28, 2026 ↗ |
| HARTFORD HEALTHCARE HLS FUND HARTFORD SERIES FUND INC | 3,460 | 791.4K $ | 0.76 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Small Cap Multi-Strategy Fund BNY MELLON FUNDS TRUST | 3,415 | 797.4K $ | 0.57 % | as of Feb 28, 2026 ↗ |
| EVOLUTIONARY TREE INNOVATORS FUND Ultimus Managers Trust | 2,986 | 697.2K $ | 3.39 % | as of Feb 28, 2026 ↗ |
| ProShares Ultra Nasdaq Biotechnology ProShares Trust | 2,835 | 662K $ | 0.72 % | as of Feb 28, 2026 ↗ |
| Developing Growth Portfolio LORD ABBETT SERIES FUND INC | 2,661 | 608.7K $ | 1.04 % | as of Mar 31, 2026 ↗ |
| International Opportunities Fund VALIC Co I | 2,619 | 611.5K $ | 0.17 % | as of Feb 28, 2026 ↗ |
| BlackRock Global Allocation V.I. Fund BlackRock Variable Series Funds, Inc. | 2,616 | 598.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| ActivePassive International Equity ETF Trust for Professional Managers | 2,602 | 607.6K $ | 0.06 % | as of Feb 28, 2026 ↗ |
| Growth Opportunities Portfolio LORD ABBETT SERIES FUND INC | 2,279 | 521.3K $ | 0.81 % | as of Mar 31, 2026 ↗ |
| Brighthouse/Wellington Balanced Portfolio Brighthouse Funds Trust II | 2,130 | 487.2K $ | 0.04 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Balanced Opportunity Fund BNY Mellon Investment Funds VI | 2,107 | 492K $ | 0.17 % | as of Feb 28, 2026 ↗ |
| Tactical Growth Allocation Fund Tactical Investment Series Trust | 2,077 | 475.1K $ | 1.30 % | as of Mar 31, 2026 ↗ |
| Penn Series SMID Cap Growth Fund Penn Series Funds Inc | 2,018 | 461.6K $ | 0.72 % | as of Mar 31, 2026 ↗ |
| Tema Heart & Health ETF Tema ETF Trust | 1,777 | 414.9K $ | 0.75 % | as of Feb 28, 2026 ↗ |
| VIP International Index Portfolio Variable Insurance Products Fund II | 1,767 | 404.2K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Sit International Growth Fund SIT MUTUAL FUNDS INC | 1,690 | 386.6K $ | 1.18 % | as of Mar 31, 2026 ↗ |
| JNL/BlackRock Global Allocation Fund JNL Series Trust | 1,685 | 385.4K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| Growth and Income Portfolio BNY MELLON VARIABLE INVESTMENT FUND | 1,674 | 382.9K $ | 0.42 % | as of Mar 31, 2026 ↗ |
| U.S. Small Cap Equity Fund RUSSELL INVESTMENT FUNDS | 1,443 | 330.1K $ | 0.16 % | as of Mar 31, 2026 ↗ |
| BNY Mellon Mid Cap Multi-Strategy Fund BNY MELLON FUNDS TRUST | 1,406 | 328.3K $ | 0.24 % | as of Feb 28, 2026 ↗ |
| Putnam VT Sustainable Future Fund Putnam Variable Trust | 1,375 | 314.5K $ | 1.20 % | as of Mar 31, 2026 ↗ |
| Putnam VT Small Cap Growth Fund Putnam Variable Trust | 1,372 | 313.8K $ | 0.84 % | as of Mar 31, 2026 ↗ |
| LVIP BlackRock Global Allocation Fund LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 1,337 | 305.8K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| AB Small Cap Growth Portfolio AB VARIABLE PRODUCTS SERIES FUND, INC. | 1,251 | 286.1K $ | 0.59 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Health Care ETF T. Rowe Price Exchange-Traded Funds, Inc. | 1,235 | 282.5K $ | 1.39 % | as of Mar 31, 2026 ↗ |
| SIMT Tax-Managed Small/Mid Cap Fund SEI INSTITUTIONAL MANAGED TRUST | 886 | 202.7K $ | 0.03 % | as of Mar 31, 2026 ↗ |
| Guardian Mid Cap Traditional Growth VIP Fund Guardian Variable Products Trust | 812 | 185.7K $ | 0.51 % | as of Mar 31, 2026 ↗ |
| Diversified Equity Master Portfolio Master Investment Portfolio | 710 | 162.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Tax-Efficient Equity Fund T. ROWE PRICE TAX-EFFICIENT FUNDS, INC. | 600 | 140.1K $ | 0.01 % | as of Feb 28, 2026 ↗ |
| Global Atlantic Wellington Research Managed Risk Portfolio Forethought Variable Insurance Trust | 590 | 135K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| AVIP AB Mid Cap Core Portfolio AuguStar Variable Insurance Products Fund Inc | 575 | 131.5K $ | 0.13 % | as of Mar 31, 2026 ↗ |
| Health Care Fund Rydex Series Funds | 526 | 120.3K $ | 0.63 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 512 | 117.1K $ | 5.48 % | as of Mar 31, 2026 ↗ |
| Biotechnology Fund Rydex Variable Trust | 476 | 108.9K $ | 1.02 % | as of Mar 31, 2026 ↗ |
| T. Rowe Price Innovation Leaders ETF T. Rowe Price Exchange-Traded Funds, Inc. | 464 | 106.1K $ | 0.70 % | as of Mar 31, 2026 ↗ |
| HUSSMAN STRATEGIC ALLOCATION FUND Hussman Investment Trust | 400 | 91.5K $ | 0.35 % | as of Mar 31, 2026 ↗ |
| Tax-Aware Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 386 | 88.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| Russell Investments U.S. Small Cap Equity ETF Russell Investments Exchange Traded Funds | 371 | 84.9K $ | 0.17 % | as of Mar 31, 2026 ↗ |
| BlackRock Balanced Fund, Inc. BlackRock Balanced Fund, Inc. | 369 | 86.2K $ | 0.00 % | as of Feb 27, 2026 ↗ |
| State Street Small-Cap Equity V.I.S. Fund STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 368 | 84.2K $ | 0.40 % | as of Mar 31, 2026 ↗ |
| TIFF MULTI-ASSET FUND TIFF Investment Program | 325 | 74.3K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| SA Multi-Managed Mid Cap Growth Portfolio SEASONS SERIES TRUST | 325 | 74.3K $ | 0.05 % | as of Mar 31, 2026 ↗ |
| Putnam Sustainable Future ETF Putnam ETF Trust | 276 | 64.4K $ | 1.15 % | as of Feb 27, 2026 ↗ |
| Health Care Fund Rydex Variable Trust | 275 | 62.9K $ | 0.50 % | as of Mar 31, 2026 ↗ |
| Overlay A Portfolio BERNSTEIN SANFORD C FUND INC | 158 | 36.1K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| First Trust IPOX Europe Equity Opportunities ETF First Trust Exchange-Traded Fund II | 118 | 27K $ | 0.58 % | as of Mar 31, 2026 ↗ |
| BlackRock Global Allocation Portfolio BlackRock Series Fund, Inc. | 103 | 23.6K $ | 0.02 % | as of Mar 31, 2026 ↗ |
| BlackRock Balanced Portfolio BlackRock Series Fund, Inc. | 87 | 19.9K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| BlackRock Managed Volatility V.I. Fund BlackRock Variable Series Funds, Inc. | 50 | 11.4K $ | 0.01 % | as of Mar 31, 2026 ↗ |
| VIFAG 2002, SICAV S.A. GESALCALA, S.A., S.G.I.I.C. | 181.5K € | 0.22 % | as of Dec 31, 2025 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Spyglass Growth Fund Manager Directed Portfolios | 5.90 % | as of Mar 31, 2026 ↗ |
| Artisan Small Cap Fund Artisan Partners Funds Inc. | 5.87 % | as of Mar 31, 2026 ↗ |
| Vitality Portfolio MORGAN STANLEY INSTITUTIONAL FUND INC | 5.48 % | as of Mar 31, 2026 ↗ |
| Artisan Mid Cap Fund Artisan Partners Funds Inc. | 5.25 % | as of Mar 31, 2026 ↗ |
| Artisan Global Discovery Fund Artisan Partners Funds Inc. | 5.19 % | as of Mar 31, 2026 ↗ |
| CTIVP - Westfield Select Large Cap Growth Fund Columbia Funds Variable Series Trust II | 5.18 % | as of Mar 31, 2026 ↗ |
| Touchstone Strategic Trust-Touchstone Mid Cap Growth Fund Touchstone Strategic Trust | 4.24 % | as of Mar 31, 2026 ↗ |
| EVOLUTIONARY TREE INNOVATORS FUND Ultimus Managers Trust | 3.39 % | as of Feb 28, 2026 ↗ |
| CTIVP - Westfield Mid Cap Growth Fund Columbia Funds Variable Series Trust II | 3.20 % | as of Mar 31, 2026 ↗ |
| American Century Focused Dynamic Growth ETF American Century ETF Trust | 3.10 % | as of Feb 28, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 176 | -57 | 14,185,164 | -31.9 % |
| 2026Q1 | 233 | -4 | 20,834,535 | -4.5 % |
| 2025Q4 | 237 | +8 | 21,811,138 | +2.8 % |
| 2025Q3 | 229 | +8 | 21,210,869 | +3.0 % |
| 2025Q2 | 221 | +4 | 20,595,618 | +1.1 % |
| 2025Q1 | 217 | -9 | 20,371,716 | +0.4 % |
| 2024Q4 | 226 | +1 | 20,284,241 | -3.4 % |
| 2024Q3 | 225 | +3 | 20,997,602 | -6.3 % |
| 2024Q2 | 222 | +12 | 22,407,066 | +8.6 % |
| 2024Q1 | 210 | -4 | 20,624,306 | -12.7 % |
| 2023Q4 | 214 | 23,636,671 |
Institutional managers
264 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10,281,496 | 2.4B $ | as of Mar 31, 2026 |
| Avoro Capital Advisors LLC | 5,062,500 | 1.2B $ | as of Mar 31, 2026 |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,813,440 | 1.1B $ | as of Mar 31, 2026 |
| FMR LLC | 3,876,601 | 886.7M $ | as of Mar 31, 2026 |
| Artisan Partners Limited Partnership | 3,230,188 | 738.8M $ | as of Mar 31, 2026 |
| FRANKLIN RESOURCES INC | 2,051,948 | 469.3M $ | as of Mar 31, 2026 |
| Capital International Investors | 1,958,843 | 448M $ | as of Mar 31, 2026 |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 1,860,669 | 425.6M $ | as of Mar 31, 2026 |
| WELLINGTON MANAGEMENT GROUP LLP | 1,757,633 | 402M $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 1,531,421 | 350.3M $ | as of Mar 31, 2026 |
| AMERICAN CENTURY COMPANIES INC | 1,397,119 | 319.6M $ | as of Mar 31, 2026 |
| Capital World Investors | 900,517 | 206M $ | as of Mar 31, 2026 |
| PRINCIPAL FINANCIAL GROUP INC | 896,397 | 205M $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 661,054 | 151.2M $ | as of Mar 31, 2026 |
| Polar Capital Holdings Plc | 651,712 | 149.1M $ | as of Mar 31, 2026 |
| MORGAN STANLEY | 606,348 | 138.7M $ | as of Mar 31, 2026 |
| GOLDMAN SACHS GROUP INC | 566,192 | 129.5M $ | as of Mar 31, 2026 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 556,427 | 127.3M $ | as of Mar 31, 2026 |
| JPMORGAN CHASE & CO | 539,434 | 117.8M $ | as of Mar 31, 2026 |
| AMERIPRISE FINANCIAL INC | 476,466 | 109M $ | as of Mar 31, 2026 |
| FIL Ltd | 447,421 | 102.3M $ | as of Mar 31, 2026 |
| Vestal Point Capital, LP | 375,000 | 85.8M $ | as of Mar 31, 2026 |
| Spyglass Capital Management LLC | 367,972 | 84.2M $ | as of Mar 31, 2026 |
| Invesco Ltd. | 362,109 | 82.8M $ | as of Mar 31, 2026 |
| SEI INVESTMENTS CO | 351,146 | 80.3M $ | as of Mar 31, 2026 |
Declared shareholders of Ascendis Pharma A/S
There are 3 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 10.50 % | 6,506,219 | as of Apr 30, 2026 · SCHEDULE 13G |
| JANUS HENDERSON GROUP PLC | 6.00 % | 3,719,452 | as of Mar 31, 2026 · SCHEDULE 13G |
| Capital International Investors | 3.20 % | 2,013,285 | as of Mar 31, 2026 · SCHEDULE 13G |
Funds holding the debt of Ascendis Pharma A/S
16 funds declare 16 bond lines of this company. The amount is the one the fund files. It is not a share of the debt, because no regulator publishes the amount outstanding in open access.
Cite this page
Titelia. "Funds holding Ascendis Pharma A/S". https://titelia.com/en/stocks/ascendis-pharma-a-s-US04351P1012